ID

39170

Description

Chinese Medicine on Deferring Dialysis Initiation; ODM derived from: https://clinicaltrials.gov/show/NCT02194946

Link

https://clinicaltrials.gov/show/NCT02194946

Keywords

Versions (1)
  1. 12/7/19 12/7/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 7, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility End-Stage Renal Disease NCT02194946

English

Eligibility End-Stage Renal Disease NCT02194946

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged 18-75 years;
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
egfr ＜15 ml/min per 1.73 m2;
Description

Estimated Glomerular Filtration Rate

Data type

boolean

Alias
UMLS CUI [1]
C3811844
non-diabetic ckd, which should be identified by biopsy or patients' medical histories.
Description

Chronic Kidney Disease Biopsy | Chronic Kidney Disease Medical History | Diabetes Mellitus Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C0005558
UMLS CUI [2,1]
C1561643
UMLS CUI [2,2]
C0262926
UMLS CUI [3,1]
C0011849
UMLS CUI [3,2]
C0332197
yellow race.
Description

Racial group Yellow

Data type

boolean

Alias
UMLS CUI [1,1]
C0034510
UMLS CUI [1,2]
C0221205
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinical indications of dialysis still occur after conservative kidney management for 1 week, which will be ruled out as hemoglobin < 70g/l; or serum potassium> 5.5mmol/l; or co2cp <13mmol/l; or epi-gfr≤5ml/min/1.73m2 ;
Description

Indication Dialysis | Status post Conservative Treatment Kidney | Hemoglobin measurement | Serum potassium measurement | Carbon dioxide combining power measurement | Glomerular Filtration Rate CKD-EPI

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0011946
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0459914
UMLS CUI [2,3]
C0022646
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0302353
UMLS CUI [5]
C0546630
UMLS CUI [6,1]
C0017654
UMLS CUI [6,2]
C2964649
pregnant or lactating.
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
critical status, such as alimentary tract hemorrhage or decompensated cirrhosis;
Description

Patient status determination, critical | Gastrointestinal Hemorrhage | Decompensated cirrhosis of liver

Data type

boolean

Alias
UMLS CUI [1]
C0184770
UMLS CUI [2]
C0017181
UMLS CUI [3]
C1619727
history of malignancy other than a successfully and completely treated carcinoma;
Description

Malignant Neoplasms | Exception Carcinoma Treated Completely

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007097
UMLS CUI [2,3]
C1522326
UMLS CUI [2,4]
C0205197
any condition (mental or physical) that would interfere with the patient's ability to comply with the study protocol;
Description

Mental condition Interferes with Protocol Compliance | Individual Physical Condition Interferes with Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C3840291
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0525058
UMLS CUI [2,1]
C3714565
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0525058
concurrent or current treatment with glucocorticoid or immunosuppressant agents in last 3 months;
Description

Glucocorticoids | Immunosuppressive Agents

Data type

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2]
C0021081
participation in any other clinical trial;
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
known or suspected allergy to certain agents involved;
Description

Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230
Back to the top of the page

Similar models

Eligibility End-Stage Renal Disease NCT02194946

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
aged 18-75 years;
boolean
C0001779 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
egfr ＜15 ml/min per 1.73 m2;
boolean
C3811844 (UMLS CUI [1])
Chronic Kidney Disease Biopsy | Chronic Kidney Disease Medical History | Diabetes Mellitus Absent
Item
non-diabetic ckd, which should be identified by biopsy or patients' medical histories.
boolean
C1561643 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C1561643 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0011849 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Racial group Yellow
Item
yellow race.
boolean
C0034510 (UMLS CUI [1,1])
C0221205 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Indication Dialysis | Status post Conservative Treatment Kidney | Hemoglobin measurement | Serum potassium measurement | Carbon dioxide combining power measurement | Glomerular Filtration Rate CKD-EPI
Item
clinical indications of dialysis still occur after conservative kidney management for 1 week, which will be ruled out as hemoglobin < 70g/l; or serum potassium> 5.5mmol/l; or co2cp <13mmol/l; or epi-gfr≤5ml/min/1.73m2 ;
boolean
C3146298 (UMLS CUI [1,1])
C0011946 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0459914 (UMLS CUI [2,2])
C0022646 (UMLS CUI [2,3])
C0518015 (UMLS CUI [3])
C0302353 (UMLS CUI [4])
C0546630 (UMLS CUI [5])
C0017654 (UMLS CUI [6,1])
C2964649 (UMLS CUI [6,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Patient status determination, critical | Gastrointestinal Hemorrhage | Decompensated cirrhosis of liver
Item
critical status, such as alimentary tract hemorrhage or decompensated cirrhosis;
boolean
C0184770 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
C1619727 (UMLS CUI [3])
Malignant Neoplasms | Exception Carcinoma Treated Completely
Item
history of malignancy other than a successfully and completely treated carcinoma;
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007097 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C0205197 (UMLS CUI [2,4])
Mental condition Interferes with Protocol Compliance | Individual Physical Condition Interferes with Protocol Compliance
Item
any condition (mental or physical) that would interfere with the patient's ability to comply with the study protocol;
boolean
C3840291 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C3714565 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
Glucocorticoids | Immunosuppressive Agents
Item
concurrent or current treatment with glucocorticoid or immunosuppressant agents in last 3 months;
boolean
C0017710 (UMLS CUI [1])
C0021081 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in any other clinical trial;
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs
Item
known or suspected allergy to certain agents involved;
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial